TransDerm is dedicated to developing therapeutics for skin disorders. In partnership with the International Pachyonychia Congenita Consortium (IPCC) and the PC Project (, we are investigating different avenues for helping patients suffering from the very rare skin disorder, pachyonychia congenita (PC). TransDerm welcomes inquiries regarding our research and partnerships to help us accomplish our goals.